FIXX
Q32 Bio Inc
$0.93
Earnings Summary
Revenue | $0Mn |
Net Profits | $-16.12Mn |
Net Profit Margins | -Inf% |
Highlights
Q32 Bio Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Q32 Bio Inc has generated NaN% jump in its revenue since last 3-months.
Q32 Bio Inc’s net profit jumped 51.06% since last year same period to $-16.12Mn in the Q4 2023. On a quarterly growth basis, Q32 Bio Inc has generated 51.09% jump in its net profits since last 3-months.
Q32 Bio Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Q32 Bio Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Q32 Bio Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.23 |
EPS Estimate Current Year | -0.23 |
Highlights
Q32 Bio Inc’s earning per share (EPS) estimates for the current quarter stand at -0.23 - a 23.33% jump from last quarter’s estimates.
Q32 Bio Inc’s earning per share (EPS) estimates for the current year stand at -0.23.
Key Ratios
Key ratios of the Q32 Bio Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.28 |
Highlights
Q32 Bio Inc’s earning per share (EPS) jumped 53.33% since last year same period to -0.28 in the Q4 2023. This indicates that the Q32 Bio Inc has generated 53.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-14 | -0.47 | -0.61 | -29.79% |
2023-05-11 | -0.53 | -0.5 | 5.66% |
2023-11-14 | -0.42 | -0.57 | -35.71% |
2024-03-13 | -0.3 | -0.28 | 6.67% |
₹0 US Stocks a/c Opening Fee